Genscript Biotech (HK:1548) has released an update.
Genscript Biotech Corporation has announced preliminary, unaudited results for its subsidiary, Legend Biotech Corporation, for the first half of 2024, after the close of trading hours on 26 July 2024. These financial results, which reflect the performance of Legend Biotech up to 30 June 2024, have been filed with the U.S. SEC and can be accessed online. Investors are cautioned to consider potential risks and to exercise caution when dealing with the company’s securities.
For further insights into HK:1548 stock, check out TipRanks’ Stock Analysis page.
